Discovery of cancer driver genes based on nucleotide context
Felix DietleiniD, Donate WeghorniD, Amaro N Taylor-WeineriD, André Richters, Brendan Michael ReardoniD, David LiuiD, Eric S. LanderiD, Eliezer M. Van AlleniD, Shamil R. SunyaeviD
Abstract
Many cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches to identify cancer driver genes are largely based on mutational recurrence, i.e. they search for genes with an increased number of nonsynonymous mutations relative to the local background mutation rate. Multiple studies have noted that the sensitivity of recurrence-based methods is limited in tumors with high background mutation rates, because passenger mutations dilute their statistical power. Here, we observe that passenger mutations tend to occur in characteristic nucleotide sequence contexts, while driver mutations follow a different distribution pattern determined by the location of functionally relevant genomic positions along the protein-coding sequence. To discover new cancer genes, we searched for genes with an excess of mutations in unusual nucleotide contexts that deviate from the characteristic context around passenger mutations. By applying this statistical framework to whole-exome sequencing data from 12,004 tumors, we discovered a long tail of novel candidate cancer genes with mutation frequencies as low as 1% and functional supporting evidence. Our results show that considering both the number and the nucleotide context around mutations helps identify novel cancer driver genes, particularly in tumors with high background mutation rates.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 255
- FWCI
- 14.88
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico saturation mutagenesis of cancer genes
F. Muinos, F. Martinez-Jimenez, … N. Lopez-Bigas·bioRxiv·Jun 3, 2020
- Finding Driver Mutations in Cancer: Elucidating the Role of Background Mutational Processes
A.-L. Brown, M. Li, … A. R. Panchenko·bioRxiv·Apr 1, 2019
- Mutation bias in driver genes reveals the distribution of effects of oncogenic mutations
Anastasia V. Stolyarova, Georgii A. Bazykin·bioRxiv·Sep 25, 2025
- Individualized discovery of rare cancer drivers in global network context
Iurii Petrov, Andrey Alexeyenko·eLifePeer-reviewed·May 20, 2022
- Learning the mutational landscape of the cancer genome
M. A. Sherman, A. Yaari, … B. Berger·bioRxiv·Aug 3, 2021
- Sequence neighborhoods enable reliable prediction of pathogenic mutations in cancer genomes
Shayantan Banerjee, Karthik Raman, Balaraman Ravindran·CancersPeer-reviewed·May 14, 2021